Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Mallaret

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Therapie|June 15, 2016
[Twenty-five years of the French Addictovigilance Network (FAN)]Joëlle Micallef, Michel Mallaret
La Revue Du Praticien|June 27, 2012
[Current knowledge on gamma-hydroxybutyric acid (GHB), gamma-butyrolactone (GBL) and 1 ,4-butanediol (1,4-BD)]Maurice Dematteis, Lucie Pennel, Michel Mallaret
Therapie|June 14, 2014
[Antidepressants and tamoxifen: an unrecognized interaction]Mélanie Moulis, Charles Khouri, Michel Mallaret
Pharmacology Research & Perspectives|April 13, 2016
The nocebo effect of drugsSara Planès, Céline Villier, Michel Mallaret
La Revue Du Praticien|April 2, 2005
[Adverse effects of marijuana]Michel Mallaret, Dominique Dal'Bo-Rohrer, Maurice Demattéis
Therapie|March 2, 2020
Pharmacovigilance and drug-induced rare diseases: Strengths of the French Network of Regional Pharmacovigilance CentresClémence Lacroix, Michel Mallaret, Annie-Pierre Jonville-Bera
Therapie|June 15, 2016
[The congress of the French Society of Pharmacology and Therapeutics celebrate in Nancy, 20 April 2016, 40 years of French Regional Pharmacovigilance Centres!]Annie-Pierre Jonville-Béra, Michel Mallaret, Catherine Sgro, et al.
The International Journal of Neuropsychopharmacology|June 14, 2019
Comment on: An Insight Into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug ReactionsEmilie Jouanjus, Joëlle Micallef, Michel Mallaret, et al.
Therapie|August 9, 2016
Medical complications of psychoactive substances with abuse risks: Detection and assessment by the network of French addictovigilance centresHélène Peyrière, Céline Eiden, Michel Mallaret, et al.
Therapie|November 8, 2019
[Safety signal detection by the French Addictovigilance Network: Innovative methods of investigation, examples and usefulness for public health]Joëlle Micallef, Émilie Jouanjus, Michel Mallaret, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Therapie|June 15, 2016
[Twenty-five years of the French Addictovigilance Network (FAN)]Joëlle Micallef, Michel Mallaret
La Revue Du Praticien|June 27, 2012
[Current knowledge on gamma-hydroxybutyric acid (GHB), gamma-butyrolactone (GBL) and 1 ,4-butanediol (1,4-BD)]Maurice Dematteis, Lucie Pennel, Michel Mallaret
Therapie|June 14, 2014
[Antidepressants and tamoxifen: an unrecognized interaction]Mélanie Moulis, Charles Khouri, Michel Mallaret
Pharmacology Research & Perspectives|April 13, 2016
The nocebo effect of drugsSara Planès, Céline Villier, Michel Mallaret
La Revue Du Praticien|April 2, 2005
[Adverse effects of marijuana]Michel Mallaret, Dominique Dal'Bo-Rohrer, Maurice Demattéis
Therapie|March 2, 2020
Pharmacovigilance and drug-induced rare diseases: Strengths of the French Network of Regional Pharmacovigilance CentresClémence Lacroix, Michel Mallaret, Annie-Pierre Jonville-Bera
Therapie|June 15, 2016
[The congress of the French Society of Pharmacology and Therapeutics celebrate in Nancy, 20 April 2016, 40 years of French Regional Pharmacovigilance Centres!]Annie-Pierre Jonville-Béra, Michel Mallaret, Catherine Sgro, et al.
The International Journal of Neuropsychopharmacology|June 14, 2019
Comment on: An Insight Into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug ReactionsEmilie Jouanjus, Joëlle Micallef, Michel Mallaret, et al.
Therapie|August 9, 2016
Medical complications of psychoactive substances with abuse risks: Detection and assessment by the network of French addictovigilance centresHélène Peyrière, Céline Eiden, Michel Mallaret, et al.
Therapie|November 8, 2019
[Safety signal detection by the French Addictovigilance Network: Innovative methods of investigation, examples and usefulness for public health]Joëlle Micallef, Émilie Jouanjus, Michel Mallaret, et al.
Pageof 5